Geron Corp (GERN)

[postman]

Research tells me there were about 1596670 cancer diagnoses expected in the US in 2011 and that about 9.5% of those were expected to be myeloid malignancies. A poster on another site claims personal knowledge that a single treatment costs about $50000. Geron's data reflects an average of slightly more than ten treatments so far for each of the 22 patients discussed. If all these best case assumptions are true, and Geron treated all diagnosed myeloid malignancies with Imetelstat, the math works out to slightly more than $75 BILLION per year in revenues. Even if it were to amount to five or ten percent of that, it's still a lot of money.